Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
Public ClinicalTrials.gov record NCT04304534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate the Efficacy and Safety of BAY 2433334 in Patients Following an Acute Myocardial Infarction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of a dual antiplatelet therapy (acetylsalicylic acid +/- clopidogrel) in patients following a recent heart attack (myocardial infarction) that happens when a blood vessel in the heart suddenly becomes blocked. BAY 2433334, works by blocking a step of the blood clotting process in our body and thins the blood and is a so called oral FXIa inhibitor.
Study identification
- NCT ID
- NCT04304534
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,601 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 17, 2020 (Actual)
- Primary completion
- Feb 21, 2022 (Actual)
- Completion
- Feb 21, 2022 (Actual)
- Last update posted
- Apr 5, 2023
2020 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valley Clinical Trials, Inc. - Covina | Covina | California | 91723 | — |
| Florida Premier Cardiology | Boynton Beach | Florida | 33437 | — |
| Clearwater Cardiovascular Associates | Clearwater, FL | Clearwater | Florida | 33756 | — |
| Cardiology Associates Research Company | Daytona Beach | Florida | 32117 | — |
| Southwest Florida Research | Naples | Florida | 34102 | — |
| Cardiology Partners Clinical Research Institute | Palm Beach Gardens | Florida | 33410 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| Reid Health | Richmond | Indiana | 47374 | — |
| Midwest Heart & Vascular Specialists | Overland Park | Kansas | 66211 | — |
| Cardiovascular Associates Research, LLC | Covington | Louisiana | 70433 | — |
| Southern Clinical Research, LLC | Zachary | Louisiana | 70791 | — |
| Maryland Cardiovascular Specialists | Baltimore | Maryland | 21229 | — |
| White Oak Medical Center | Silver Spring | Maryland | 20904 | — |
| St. Mary's/Duluth Clinic Health System | Duluth | Minnesota | 55805 | — |
| Logan Health Research | Kalispell | Montana | 59901 | — |
| Methodist Physicians Clinic | Omaha | Nebraska | 68114 | — |
| The Valley Hospital, Inc. | Ridgewood | New Jersey | 07450 | — |
| Trinity Medical WNY | Cheektowaga | New York | 14227 | — |
| Jefferson Heart Institute | Philadelphia | Pennsylvania | 19107 | — |
| Cardiovascular Research of Knoxville | Powell | Tennessee | 37849 | — |
| PharmaTex Research, LLC | Amarillo | Texas | 79109 | — |
| North Texas Research Associates | McKinney | Texas | 75071 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 138 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04304534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04304534 live on ClinicalTrials.gov.